1999
DOI: 10.1152/ajpendo.1999.277.3.e537
|View full text |Cite
|
Sign up to set email alerts
|

Glucose and amino acid kinetic response to graded infusion of rhIGF-I in the late gestation ovine fetus

Abstract: Insulin-like growth factor I (IGF-I) has anabolic effects and is thought to be important in fetal development. The present study was designed to determine the dose response of recombinant human (rh) IGF-I on ovine fetal glucose and amino acid kinetics. Chronically catheterized fetal lambs were studied at 122–127 days gestation. The kinetics of leucine, phenylalanine, and glucose were measured before and during the infusion of rhIGF-I. rhIGF-I was infused into the fetal inferior vena cava at low, medium, or hig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
13
0

Year Published

2001
2001
2023
2023

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 18 publications
1
13
0
Order By: Relevance
“…Then, the fetus was infused with one of the following four infusates: 1) saline, 2) recombinant human (rh)IGF-I (gift of Eli Lilly Research Laboratories, Indianapolis, IN) plus a replacement dose of insulin (40 nmol IGF-I/h ϩ 16 mIU insulin/h), 3) insulin (890 mIU/h), and 4) IGF-I plus insulin (40 nmol IGF-I/h ϩ 890 mIU insulin/h). The infusion rates of insulin and IGF-I are similar to those of our previous work, have been shown to result in phamacological concentrations of insulin and IGF-I, and have been shown to affect amino acid and protein kinetics in the ovine fetus (4,30,31). The dose of insulin infused in group 2 was expected to maintain plasma insulin concentrations at the baseline level, counteracting the inhibition of insulin secretion during the rhIGF-I infusion.…”
Section: Methodssupporting
confidence: 54%
“…Then, the fetus was infused with one of the following four infusates: 1) saline, 2) recombinant human (rh)IGF-I (gift of Eli Lilly Research Laboratories, Indianapolis, IN) plus a replacement dose of insulin (40 nmol IGF-I/h ϩ 16 mIU insulin/h), 3) insulin (890 mIU/h), and 4) IGF-I plus insulin (40 nmol IGF-I/h ϩ 890 mIU insulin/h). The infusion rates of insulin and IGF-I are similar to those of our previous work, have been shown to result in phamacological concentrations of insulin and IGF-I, and have been shown to affect amino acid and protein kinetics in the ovine fetus (4,30,31). The dose of insulin infused in group 2 was expected to maintain plasma insulin concentrations at the baseline level, counteracting the inhibition of insulin secretion during the rhIGF-I infusion.…”
Section: Methodssupporting
confidence: 54%
“…We and others have documented that regulation of fetal growth results from a complex interaction between substrate supply and the resulting hormonal milieu (17,19,22,38,39). Our previous studies have demonstrated that glucose concentration was a significant factor determining amino acid catabolism and accretion (21,23).…”
Section: Discussionmentioning
confidence: 97%
“…Further IGF-I infusion to fetal sheep results in anabolic effects with increased transplacental amino acid and glucose uptake and decreased fetal protein breakdown (34,35). In a recent study in mice, administration of IGF-I was associated with higher weight gain and higher endogenous IGF-I levels (36).…”
Section: Discussionmentioning
confidence: 99%